These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1609775

  • 1. Coagulation factor IX: successful surgical experience with a purified factor IX concentrate.
    Goldsmith JC, Kasper CK, Blatt PM, Gomperts ED, Kessler CM, Thompson AR, Herring SW, Novak PL.
    Am J Hematol; 1992 Jul; 40(3):210-5. PubMed ID: 1609775
    [Abstract] [Full Text] [Related]

  • 2. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC, Shapiro AD, Kurczynski EM, Kim HC, Bergman GE.
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [Abstract] [Full Text] [Related]

  • 3. Substitution treatment of hemophilia a and b.
    Duckert F.
    Schweiz Med Wochenschr; 1975 Jun 14; 105(24):783-4. PubMed ID: 1145162
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Disseminated intravascular coagulation and hemorrhage in hemophilia B following elective surgery.
    Conlan MG, Hoots WK.
    Am J Hematol; 1990 Nov 14; 35(3):203-7. PubMed ID: 2220765
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and in vivo properties of high purity factor IX concentrates.
    Berntorp E, Björkman S, Carlsson M, Lethagen S, Nilsson IM.
    Thromb Haemost; 1993 Nov 15; 70(5):768-73. PubMed ID: 8128433
    [Abstract] [Full Text] [Related]

  • 7. Immunoaffinity purification of factor IX from commercial concentrates and infusion studies in animals.
    Smith KJ.
    Blood; 1988 Oct 15; 72(4):1269-77. PubMed ID: 3262386
    [Abstract] [Full Text] [Related]

  • 8. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Bottasso B, Simoni L, Rosenberg RD.
    Blood; 1990 Dec 15; 76(12):2540-5. PubMed ID: 2265248
    [Abstract] [Full Text] [Related]

  • 9. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.
    Santagostino E, Mannucci PM, Gringeri A, Tagariello G, Baudo F, Bauer KA, Rosenberg RD.
    Thromb Haemost; 1994 Jun 15; 71(6):737-40. PubMed ID: 7974341
    [Abstract] [Full Text] [Related]

  • 10. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul 15; 153(2):147-57. PubMed ID: 7600466
    [Abstract] [Full Text] [Related]

  • 11. Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy.
    Ohga S, Saito M, Matsukazi A, Kai T, Ueda K.
    Br J Haematol; 1993 Jun 15; 84(2):343-5. PubMed ID: 8398841
    [Abstract] [Full Text] [Related]

  • 12. A cross-over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrate.
    Thomas DP, Hampton KK, Dasani H, Lee CA, Giangrande PL, Harman C, Lee ML, Preston FE.
    Br J Haematol; 1994 Aug 15; 87(4):782-8. PubMed ID: 7986719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Why prescribe highly purified factor VIII and IX concentrates?
    Berntorp E.
    Vox Sang; 1996 Aug 15; 70(2):61-8. PubMed ID: 8801765
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Orthotopic liver transplantation in a patient with combined hemophilia A and B.
    Delorme MA, Adams PC, Grant D, Ghent CN, Walker IR, Wall WJ.
    Am J Hematol; 1990 Feb 15; 33(2):136-8. PubMed ID: 2105634
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B.
    Djulbegovic B, Marasa M, Pesto A, Kushner GM, Hadley T, Joseph G, Goldsmith G.
    Am J Hematol; 1996 Feb 15; 51(2):168-70. PubMed ID: 8579061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.